NORCROSS, Ga.--(BUSINESS WIRE)--Auriga Laboratories, Inc. (OTCBB:ARGA), a specialty pharmaceutical company with products for the treatment of acute respiratory diseases, dermatological conditions, and Xerostomia (or “dry mouth”), said it reached a settlement agreement with Athlon Pharmaceuticals, Inc. regarding a dispute between the parties related to its license agreement between Auriga and Athlon, which provided Auriga an exclusive license to certain pharmaceutical products developed by Athlon, including the Levall brand of cough and cold medication.
